David J. Main

2018

In 2018, David J. Main earned a total compensation of $4.2M as Former Chief Executive Officer and President at Aquinox Pharmaceuticals, a 39% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$267,500
Option Awards$3,413,647
Salary$535,000
Other$10,139
Total$4,226,286

Main received $3.4M in option awards, accounting for 81% of the total pay in 2018.

Main also received $267.5K in non-equity incentive plan, $535K in salary and $10.1K in other compensation.

Rankings

In 2018, David J. Main's compensation ranked 2,587th out of 14,244 executives tracked by ExecPay. In other words, Main earned more than 81.8% of executives.

ClassificationRankingPercentile
All
2,587
out of 14,244
82nd
Division
Manufacturing
952
out of 5,765
84th
Major group
Chemicals And Allied Products
323
out of 2,128
85th
Industry group
Drugs
262
out of 1,817
86th
Industry
Pharmaceutical Preparations
205
out of 1,391
85th
Source: SEC filing on October 2, 2019.

Main's colleagues

We found two more compensation records of executives who worked with David J. Main at Aquinox Pharmaceuticals in 2018.

2018

Lloyd Mackenzie

Aquinox Pharmaceuticals

Chief Operating Officer

2018

Kamran Alam

Aquinox Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like